scroll to top
Loading icon
0

Mobile Menu

Header Layout

EBSCO Auth Banner

Let's find your institution. Click here.

Page title

Advanced Search Results For "human rights"

1 - 10 of 2,106 results for
 "human rights"
Results per page:

GCN5 contributes to intracellular lipid accumulation in human primary cardiac stromal cells from patients affected by Arrhythmogenic cardiomyopathy.

Publication Type:Academic Journal

Source(s):Journal of cellular and molecular medicine [J Cell Mol Med] 2022 Jul; Vol. 26 (13), pp. 3687-3701. Date of Electronic Publication: 2022 Jun 16.

Abstract:Arrhythmogenic cardiomyopathy (ACM) is a genetic disease associated with sudden cardiac death and cardiac fibro-fatty replacement. Over the last years, several works have demonstrated that different epigenetic enzymes can affect not only gene expressio...

View details

Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy.

Publication Type:Editorial & Opinion

Source(s):Journal of the American Heart Association [J Am Heart Assoc] 2022 Jul 05; Vol. 11 (13), pp. e026874. Date of Electronic Publication: 2022 Jun 29.

View details

Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy.

Publication Type:Academic Journal

Source(s):Journal of the American Heart Association [J Am Heart Assoc] 2022 Jul 05; Vol. 11 (13), pp. e024634. Date of Electronic Publication: 2022 Jun 29.

Abstract:Background Patients with arrhythmogenic right ventricular cardiomyopathy are at risk for life-threatening ventricular tachyarrhythmias, but progressive heart failure (HF) may occur in later stages of disease. This study aimed to characterize potential ...

View details

Right atrial strain and cardiovascular outcome in arrhythmogenic right ventricular cardiomyopathy.

Publication Type:Academic Journal

Source(s):European heart journal. Cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2022 Jun 21; Vol. 23 (7), pp. 970-978.

Abstract:Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterized by progressive fibro-fatty infiltration of the myocardium and associated with adverse cardiovascular (CV) events. This study aims to examine right atrial (RA) deformation in ...

View details

Reply to the Letter to the Editor entitled "The importance of anti-fibrotic drugs as first-line therapy in patients with arrhythmogenic right ventricular dysplasia".

Publication Type:Editorial & Opinion

Source(s):International journal of cardiology [Int J Cardiol] 2022 Aug 15; Vol. 361, pp. 49. Date of Electronic Publication: 2022 May 05.

View details

Novel homozygous stop-gain pathogenic variant of PPP1R13L gene leads to arrhythmogenic cardiomyopathy.

Publication Type:Academic Journal

Source(s):BMC cardiovascular disorders [BMC Cardiovasc Disord] 2022 Aug 06; Vol. 22 (1), pp. 359. Date of Electronic Publication: 2022 Aug 06.

Abstract:Background: Arrhythmogenic cardiomyopathy (ACM) is a heritable cardiac disease with two main features: electric instability and myocardial fibro-fatty replacement. There is no defined treatment except for preventing arrhythmias and sudden death. Detect...

View details

Generation of two induced pluripotent stem cell lines carrying the phospholamban R14del mutation for modeling ARVD/C.

Publication Type:Academic Journal

Source(s):Stem cell research [Stem Cell Res] 2022 Aug; Vol. 63, pp. 102834. Date of Electronic Publication: 2022 Jun 06.

Abstract:The phospholamban (PLN) R14del mutation is associated with arrhythmogenic right ventricular dysplasia (ARVD/C). ARVD/C is a cardiac disease characterized by arrhythmias and structural abnormalities in the right ventricle. Because PLN is a regulator of ...

View details

Reply to letter "The effect of beta-blocker on sudden cardiac death in arrhythmogenic right ventricle cardiomyopathy remains to be considered" by Zhenyu Dong et al.

Publication Type:Editorial & Opinion

Source(s):International journal of cardiology [Int J Cardiol] 2022 Aug 01; Vol. 360, pp. 45. Date of Electronic Publication: 2022 May 04.

View details

Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy.

Publication Type:Academic Journal

Source(s):Heart rhythm [Heart Rhythm] 2022 Aug; Vol. 19 (8), pp. 1315-1324. Date of Electronic Publication: 2022 Apr 22.

Abstract:Background: Desmoplakin (DSP) genetic variants have been reported in arrhythmogenic cardiomyopathy with particular regard to predominant left ventricular (LV) involvement.Objective: The purpose of this study was to improve our understanding of clinical...

View details

A Drosophila melanogaster model for TMEM43-related arrhythmogenic right ventricular cardiomyopathy type 5.

Publication Type:Academic Journal

Source(s):Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2022 Jul 22; Vol. 79 (8), pp. 444. Date of Electronic Publication: 2022 Jul 22.

Abstract:Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a severe cardiac disease that leads to heart failure or sudden cardiac death (SCD). For the pathogenesis of ARVC, various mutations in at least eight different genes have been identified. A rare...

View details

banner_970x250 (970x250)

sponsored